Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells
Journal of Clinical Investigation · 03.03.2025 · 135 (5)
DOI: 10.1172/jci184069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 09.01.2025. Verfasst von Jue Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Carnitine O-Palmitoyltransferase, Hematopoietic Stem Cells, Oxidative Phosphorylation, Mitochondria. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) rely on self-renewal to sustain stem cell potential and undergo differentiation to generate mature blood cells. Mitochondrial fatty acid β-oxidation (FAO) is essential for HSC maintenance. However, the role of carnitine palmitoyl transferase 1a (CPT1A), a key enzyme in FAO, remains unclear in HSCs. Using a Cpt1a hematopoiesis-specific conditional-KO ( Cpt1a Δ / Δ ) mouse model, we found that loss of Cpt1a led to HSC defects, including loss of HSC quiescence and self-renewal and increased differentiation. Mechanistically, we found that loss of Cpt1a resulted in elevated levels of mitochondrial respiratory chain complex components and their activity, as well as increased ATP production and accumulation of mitochondrial ROS in HSCs. Taken together, this suggests hyperactivation of mitochondria and metabolic rewiring via upregulated glucose-fueled oxidative phosphorylation (OXPHOS). In summary, our findings demonstrate an essential role for Cpt1a in HSC maintenance and provide insight into the regulation of mitochondrial metabolism via control of the balance between FAO and glucose-fueled OXPHOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.
- Department of Cell Systems and Anatomy, UT Health San Antonio, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA.
- Mays Cancer Center at UT Health San Antonio, San Antonio, Texas, USA.
- Department of Pathology and Laboratory Medicine, UT Health San Antonio, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA.
- Department of Microbiology, Immunology and Molecular Genetics, UT Health San Antonio, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Li, J., Bai, J., Pham, V. T., Hashimoto, M., Sezaki, M., Shi, Q., Jin, Q., He, C., Armstrong, A., Li, T., Pan, M., Liu, S., Luan, Y., Zeng, H., Andreassen, P. R., & Huang, G. (2025). Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells. Journal of Clinical Investigation, 135(5). https://doi.org/10.1172/jci184069
Vancouver
Li J, Bai J, Pham VT, Hashimoto M, Sezaki M, Shi Q, et al. Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells. Journal of Clinical Investigation. 2025;135(5). doi:10.1172/jci184069
BibTeX
@article{Li2025,
author = {Li, Jue and Bai, Jie and Pham, Vincent T and Hashimoto, Michihiro and Sezaki, Maiko and Shi, Qili and Jin, Qiushi and He, Chenhui and Armstrong, Amy and Li, Tian and Pan, Mingzhe and Liu, Shujun and Luan, Yu and Zeng, Hui and Andreassen, Paul R and Huang, Gang},
title = {Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {5},
doi = {10.1172/jci184069}
}
EUVIMED